Merit Financial Group’s ImmunityBio IBRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $130K | Buy |
49,175
+4,931
| +11% | +$13K | ﹤0.01% | 1609 |
|
|
2025
Q1 | $133K | Buy |
44,244
+435
| +1% | +$1.31K | ﹤0.01% | 1339 |
|
|
2024
Q4 | $112K | Buy |
43,809
+9
| +0% | +$23 | ﹤0.01% | 1124 |
|
|
2024
Q3 | $163K | Sell |
43,800
-19
| -0% | -$71 | ﹤0.01% | 797 |
|
|
2024
Q2 | $277K | Buy |
43,819
+7
| +0% | +$44 | 0.01% | 752 |
|
|
2024
Q1 | $401K | Buy |
43,812
+12
| +0% | +$110 | 0.01% | 610 |
|
|
2023
Q4 | $220K | Hold |
43,800
| – | – | 0.01% | 701 |
|
|
2023
Q3 | $74K | Buy |
43,800
+20,000
| +84% | +$33.8K | ﹤0.01% | 725 |
|
|
2023
Q2 | $66.2K | Hold |
23,800
| – | – | ﹤0.01% | 722 |
|
|
2023
Q1 | $43.3K | Buy |
+23,800
| New | +$43.3K | ﹤0.01% | 612 |
|